...
首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins?
【24h】

Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins?

机译:人类诱导的多能干细胞和胚胎干细胞的比较:异卵双胞胎还是同卵双胞胎?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Human induced pluripotent stem cells L(hiPSCs) have been hailed as an effective replacement for human embryonic stem cells (hESCs) and a prime candidate cell source for regenerative medicine aims. Both hESCs and hiPSCs share the important properties of self-renewal and pluripotency; that is, they are theoretically capable of generating unlimited amounts of any differentiated cell in the human body. However, accumulating reports of gene expression differences between hESCs and hiPSCs have led many to question the equivalence of these two promising cell types. Seemingly random variation in the differentiation propensity of hiPSCs to neural, cardiovascular, and hemangioblastic lineages has frustrated investigators hoping to better exploit their potential for disease modeling and cell replacement therapies
机译:人类诱导的多能干细胞L(hiPSC)被誉为人类胚胎干细胞(hESCs)的有效替代品,也是再生医学目标的主要候选细胞来源。 hESC和hiPSC都具有自我更新和多能性的重要特性。也就是说,从理论上讲,它们能够在人体中产生无限量的任何分化细胞。但是,关于hESC和hiPSC之间基因表达差异的报道不断,这使许多人质疑这两种有前途的细胞类型的等效性。 hiPSC对神经,心血管和成血管细胞谱系分化倾向的随机变化似乎使研究人员感到沮丧,他们希望能够更好地利用其在疾病建模和细胞替代疗法中的潜力

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号